safety profile, high patient satisfaction, and improved well-being.2,3,6

Galderma will also be hosting a Relfydess Masterclass at TOXINS 2026 in which expert speakers, Dr. Joanna Czuwara and Dr. Birgit Blessman-Gurk, will discuss clinical data, real-world treatment experience, and the science behind Relfydess’ PEARL Technology. The session will feature insights into its rapid onset, long duration, and scientific differentiation principles and will take place from15:50 – 16:20 CETonThursday, January 15in theEducational Theatre.

Furthermore, abstracts investigating patient and practitioner satisfaction when using Dysport to treat frown lines will also be presented at the conference, including results from a real-world study of repeated Dysport treatment in China showing up to 100% patient satisfaction three weeks after three treatment cycles.4,5

Establishing clear leadership in neuromodulation

Galderma’s data and activities at TOX
=*=*=*=*=*=
当前为第4/10页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页